Arrowhead Research reported $21.3M in Sales Revenues for its fourth fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Agios Pharmaceuticals AGIO:US $ 44.04M 9.34M
Alnylam Pharmaceuticals ALNY:US $ 163.56M 37.71M
Arena Pharmaceuticals ARNA:US $ 0.04M 0.02M
Arrowhead Research ARWR:US $ 21.3M 13.67M
Bluebird Bio BLUE:US $ 10.71M 8.56M
Dicerna Pharmaceuticals DRNA:US $ 40.96M 7.92M
Heron Therapeutics HRTX:US $ 20.6M 0.64M
Intercept Pharmaceuticals ICPT:US $ 83.27M 3.75M
Ligand Pharmaceuticals LGND:US $ 69.99M 28.14M
Merk MRK:US $ 12515M 36M
Mirati Therapeutics MRTX:US $ 1.71M 9.72M
Moderna Inc MRNA:US 570.74M 412.84M
Nektar Therapeutics NKTR:US $ 23.46M 6.57M
Novartis NOVN:VX SF 13030M 492M
Opko Health OPK:US $ 494.67M 66.61M
Spectrum Pharmaceuticals SPPI:US $ 0M 0M
Ultragenyx Pharmaceutical RARE:US $ 91.54M 10.07M
Vertex Pharmaceuticals VRTX:US $ 1627.82M 89.55M
Xencor XNCR:US $ 41.85M 6.49M
YTE INCY:US $ 789.51M 168.87M